[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DelveInsight: Market Research Reports

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:

  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.


This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.

Publications found: 3,777
Sort by:
Acromegaly – Pipeline Insight, 2020 US$ 2,000.00

... clients within 48 Hours 'Acromegaly - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Acromegaly development. The report provides detailed ...

September 2020 90 pages
Cancer Cachexia – Pipeline Insight, 2020 US$ 1,500.00

... clients within 48 Hours 'Cancer Cachexia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cancer Cachexia development. The report provides ...

September 2020 68 pages
Idiopathic Pulmonary Fibrosis (IPF) – Pipeline Insight, 2020 US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2019 The ...

September 2020 100 pages
Sarcopenia - Epidemiology Forecast to 2030 US$ 3,750.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Sarcopenia Key assessments Patient Segmentation in Sarcopenia Sarcopenia Risk & Burden Factors driving growth in a specific Sarcopenia patient population

September 2020 60 pages
Uveitis – Pipeline Insight, 2020 US$ 1,500.00

... clients within 72 Hours 'Uveitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Uveitis development. The report provides detailed ...

September 2020 63 pages
Acromegaly - Epidemiology Forecast–2030 US$ 3,750.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Acromegaly Key assessments Patient Segmentation in Acromegaly Acromegaly Risk & Burden Factors driving growth in a specific Acromegaly patient population

September 2020 100 pages
Cutaneous T-cell Lymphoma - Epidemiology Forecast to 2030 US$ 3,750.00

... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Cutaneous T-Cell Lymphoma(CTCL) Key assessments Patient Segmentation in Cutaneous T-Cell Lymphoma(CTCL) Cutaneous T-Cell Lymphoma(CTCL) Risk & Burden Factors driving growth in a specific Cutaneous T-Cell Lymphoma(CTCL) patient ...

September 2020 108 pages
Gastroparesis - Epidemiology Forecast - 2030 US$ 3,750.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gastroparesis Key assessments Patient Segmentation in Gastroparesis Gastroparesis Risk & Burden Factors driving growth in a specific Gastroparesis patient population

September 2020 100 pages
Interstitial Cystitis (IC) – Pipeline Insight, 2020 US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Interstitial Cystitis-Pipeline Insight, 2019 The report also ...

September 2020 75 pages
Dilated Cardiomyopathy – Pipeline Insight, 2020 US$ 1,500.00

... clients within 48 Hours 'Dilated Cardiomyopathy - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dilated Cardiomyopathy development. The report provides ...

September 2020 67 pages
Essential Thrombocythemia (ET) – Pipeline Insight, 2020 US$ 1,500.00

... clients within 48 Hours 'Essential Thrombocythemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Essential Thrombocythemia development. The report provides ...

September 2020 66 pages
Exocrine Pancreatic Insufficiency (EPI) – Pipeline Insight, 2020 US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Exocrine Pancreatic Insufficiency The report also ...

September 2020 71 pages
Non-Small Cell Lung Cancer (NSCLC) – Pipeline Insight, 2020 US$ 5,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Non-Small Cell Lung Cancer The report also ...

September 2020 200 pages
Peanut Allergy – Pipeline Insight, 2020 US$ 2,000.00

... clients within 48 Hours 'Peanut Allergy - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Peanut Allergy development. The report provides ...

September 2020 75 pages
Pompe Disease – Pipeline Insight, 2020 US$ 2,500.00

... clients within 48 Hours 'Pompe Disease - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pompe Disease development. The report provides ...

September 2020 90 pages
Pulmonary Arterial Hypertension (PAH) – Pipeline Insight, 2020 US$ 2,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Pulmonary Arterial Hypertension The report also ...

September 2020 102 pages
Spinal Muscular Atrophy – Pipeline Insight, 2020 US$ 2,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Spinal Muscular Atrophy (SMA) The report also ...

September 2020 75 pages
Glioblastoma multiforme (GBM) - Epidemiology Forecast to 2030 US$ 3,750.00

... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Glioblastoma multiforme (GBM) Key assessments Patient Segmentation in Glioblastoma multiforme (GBM) Glioblastoma multiforme (GBM) Risk & Burden Factors driving growth in a specific Glioblastoma multiforme (GBM) patient population ...

September 2020 100 pages
Multiple Myeloma - Epidemiology Forecast to 2030 US$ 7,140.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Multiple Myeloma Key assessments Patient Segmentation in Multiple Myeloma Multiple Myeloma Risk & Burden Factors driving growth in a specific Multiple Myeloma patient population

September 2020 200 pages
Sjogren’s syndrome - Epidemiology Forecast - 2030 US$ 3,750.00

... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Sjogren's Syndrome Key assessments Patient Segmentation in Sjogren's Syndrome Sjogren's Syndrome Risk & Burden Factors driving growth in a specific Sjogren's Syndrome patient population

September 2020 100 pages
Pemphigus Vulgaris (PV)-Epidemiology Forecast–2030 US$ 3,750.00

... leaders. Pemphigus Vulgaris Epidemiology Segmentation The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [total prevalent cases, prevalent cases by Severity (Mild, Moderate and Severe), diagnosed and ...

September 2020 100 pages
Aneurysmal Subarachnoid Hemorrhage (ASH) – Pipeline Insight, 2020 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, Aneurysmal Subarachnoid Hemorrhage (ASH) – Pipeline Insight, 2020,” report provides comprehensive insights about 10+ compa...

September 2020 69 pages
Fibrodysplasia Ossificans Progressiva (FOP) – Pipeline Insight, 2020 US$ 1,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Fibrodysplasia Ossificans Progressiva (FOP) – Pipeline Insight, 2020,” report provides comprehensive insights about 7+ co...

September 2020 60 pages
Focal Segmental Glomerulosclerosis (FSGS) – Pipeline Insight, 2020 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Focal Segmental Glomerulosclerosis (FSGS) – Pipeline Insight, 2020,” report provides comprehensive insights about 15+ com...

September 2020 61 pages
Frontotemporal Dementia (FTD) – Pipeline Insight, 2020 US$ 1,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Frontotemporal Dementia (FTD) – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companies and 5+...

September 2020 60 pages
Immune Thrombocytopenia – Pipeline Insight, 2020 US$ 2,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Immune Thrombocytopenia – Pipeline Insight, 2020,” report provides comprehensive insights about 50+ companies and 50+ pip...

September 2020 103 pages
Non-cystic Fibrosis Bronchiectasis (NCFB) – Pipeline Insight, 2020 US$ 1,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Non-cystic Fibrosis Bronchiectasis (NCFB) – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ comp...

September 2020 60 pages
Onychomycosis – Pipeline Insight, 2020 US$ 1,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Onychomycosis – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs...

September 2020 75 pages
Postpartum Depression – Pipeline Insight, 2020 US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Postpartum Depression – Pipeline Insight, 2020,” report provides comprehensive insights about 2+ companies and 2+ pipelin...

September 2020 55 pages
Prader-Willi syndrome – Pipeline Insight, 2020 US$ 2,000.00

This report can be delivered to the clients within 72 - 96 Hours DelveInsight’s, “Prader-Willi syndrome – Pipeline Insight, 2020,” report provides comprehensive insights about 20+ companies and 20+...

September 2020 90 pages
Uterine fibroids – Pipeline Insight, 2020 US$ 2,000.00

This report can be delivered to the clients within 72 - 96 Hours DelveInsight’s, “Uterine fibroids – Pipeline Insight, 2020,” report provides comprehensive insights about 25+ companies and 25+ pipel...

September 2020 75 pages
Biliary Atresia (BA) - Epidemiology Forecast - 2030 US$ 3,750.00

This report can be delivered to the clients within 24 Hours DelveInsight’s ‘Biliary Atresia (BA)– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Biliary Atresia, histor...

September 2020 100 pages
Complement 3 Glomerulopathy (C3G) - Epidemiology Forecast – 2030 US$ 3,750.00

This report can be delivered to the clients within 24 Hours DelveInsight’s ‘Complement 3 Glomerulopathy (C3G) - Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease...

September 2020 100 pages
Follicular Lymphoma - Epidemiology Forecast to 2030 US$ 3,750.00

This report can be delivered to the clients within 24 Hours DelveInsight’s ‘Follicular Lymphoma - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical,...

September 2020 100 pages
Hypofibrinogenemia - Epidemiology Forecast - 2030 US$ 3,750.00

This report can be delivered to the clients within 24 Hours DelveInsight’s ‘Hypofibrinogenemia– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Hypofibrinogenemia, histo...

September 2020 100 pages
Non-muscle Invasive Bladder Cancer (NMIBC) - Epidemiology Forecast–2030 US$ 3,750.00

This report can be delivered to the clients within 24 Hours DelveInsight’s ‘Non-muscle Invasive Bladder Cancer (NMIBC)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the di...

September 2020 100 pages
Primary Sclerosing Cholangitis - Epidemiology Forecast to 2030 US$ 3,750.00

This report can be delivered to the clients within 24 Hours DelveInsight’s ‘Primary Sclerosing Cholangitis - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease,...

September 2020 80 pages
West Syndrome - Epidemiology Forecast - 2030 US$ 3,750.00

This report can be delivered to the clients within 24 Hours DelveInsight’s ‘West Syndrome - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forec...

September 2020 100 pages
177-LUTETIUM-PSMA-617- Emerging Drug Insight and Market Forecast – 2030 US$ 3,250.00

This report can be delivered to the clients within 48 Hours “177-LUTETIUM-PSMA-617- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigatio...

September 2020 50 pages
AAV2/8 LSPHGAA - Emerging Drug Insight and Market Forecast – 2030 US$ 3,250.00

This report can be delivered to the clients within 48 Hours “AAV2/8 LSPHGAA - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational pr...

September 2020 50 pages
ACE-536 (Luspatercept)- Drug Insight and Market Forecast – 2030 US$ 2,750.00

This report can be delivered to the clients within 48 Hours “ACE-536 (Luspatercept)- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product ind...

September 2020 50 pages
AT845 - Emerging Drug Insight and Market Forecast – 2030 US$ 3,250.00

This report can be delivered to the clients within 48 Hours “AT845 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for...

September 2020 50 pages
AVR RD 01 - Emerging Drug Insight and Market Forecast – 2030 US$ 3,250.00

This report can be delivered to the clients within 48 Hours “AVR RD 01 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product...

September 2020 50 pages
BERCOLAGENE TELSERPAVEC (KB103)- Emerging Drug Insight and Market Forecast – 2030 US$ 3,250.00

This report can be delivered to the clients within 48 Hours “BERCOLAGENE TELSERPAVEC (KB103)- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an in...

September 2020 50 pages
BLU 782- Emerging Drug Insight and Market Forecast – 2030 US$ 3,250.00

This report can be delivered to the clients within 48 Hours “BLU 782- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...

September 2020 50 pages
DNX-2401 (Tasadenoturev) - Emerging Drug Insight and Market Forecast – 2030 US$ 3,250.00

This report can be delivered to the clients within 48 Hours “DNX-2401 (Tasadenoturev) - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investig...

September 2020 50 pages
EB 101- Emerging Drug Insight and Market Forecast – 2030 US$ 3,250.00

This report can be delivered to the clients within 48 Hours “EB 101- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for...

September 2020 50 pages
FCX-007- Emerging Drug Insight and Market Forecast – 2030 US$ 3,250.00

This report can be delivered to the clients within 48 Hours “FCX-007- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...

September 2020 50 pages
FLT190 - Emerging Drug Insight and Market Forecast – 2030 US$ 3,250.00

This report can be delivered to the clients within 48 Hours “FLT190 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...

September 2020 50 pages
GARETOSMAB (REGN2477)- Emerging Drug Insight and Market Forecast – 2030 US$ 3,250.00

This report can be delivered to the clients within 48 Hours “GARETOSMAB (REGN2477)- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigatio...

September 2020 50 pages

Filters

Search

Categories

10
3,003
446
318

Publishers

3,777

Regions

3,777

Price

Date

Pages

Offers